Dr. Stephen G. Gray's Linkedin Analytics

𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗖𝗵𝗶𝗲𝗳 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 (𝗖𝗘𝗢) 𝗼𝗳 𝗡𝗼𝘂𝗕𝗶𝗼 𝗜𝗻𝗰 🇺🇸: A company focused on the bio-intelligent manufacturing of animal serum replacements & deep technologies to reduce the costs of cell-based biomanufacturing by 95% & scale production. NouBio will unlock the reality of the trillion dollar bioeconomy. NouBio's deep technologies can scale production in the industries of cell-therapies, cell-vaccines, bio-similars, human tissue development, drug discovery, regenerative medicine, cell-based foods & synthetic biology. NouBio raised venture capital investment from Big Idea Ventures & angels. First product: NouSerum: A full Fetal Bovine Serum (FBS) replacement that reduces production costs by 50-95% whilst maintaining the same performance as FBS. NouSerum: -Contains 300 serum proteins found in FBS -Is in the GRAS category of FDA -Free from GMOs -Powder based for scalability -Antimicrobial to reduce contamination -Can be stored at room temperature Future products: -Cost-effective, bio-degradable microcarriers with no need to remove cells in bioreactors -An artificial intelligence driven robotic cellular farm to replace the need for bioreactors 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿: 𝗢𝘂𝗿𝗼𝗯𝗶𝗼𝗻𝗶𝗰𝘀 🇳🇱: A company focused on multi-complex 3D tissue production with biosensors to scale cell-based biomanufacturing. Ourobionics funded by €1 billion NxtGenHighTech fund as partner in facility for advanced biofabrication of human tissue, artificial organs until 2030. Ourobionics raised venture capital investment from OOST-NL and angels. Ourobionics patent & patent pending platform CHIMERA launched with 5 technologies: 1. 3D Bio-ElectroSpraying 2. 3D Cell-ElectroSpinning 3. 3D Bio-ElectroJetting 4. 3D Melt/Cell-ElectroWriting 5. 3D BioPrinting 𝗙𝗼𝘂𝗻𝗱𝗲𝗿: 𝗖𝘆𝗯𝗼𝘀𝗲𝗻𝘀𝗲 🇳🇱: Self-healing bioelectronics & bio-sensors for health, military, & space applications 𝗩𝘂𝗹𝗽𝗶𝗻𝗲 𝗟𝗮𝗯𝘀 🇺🇸: End-end biocomputing software & DNA code processing unit for writing, &analysis of mRNA, & proteins with cloud database & generative AI. 𝗙𝗶𝗿𝘀𝘁 𝗦𝘁𝗮𝗿𝘁𝘂𝗽: 𝗢𝘂𝗿𝗼𝗯𝗼𝘁𝗶𝗰𝘀 𝗟𝘁𝗱 (𝟮𝟬𝟭𝟯-𝟮𝟬𝟭𝟲) Founded by CEO Jemma Redmond in 2013 as worlds first robotic arm 10 material bioprinting company & disrupted the industry. Voted "Top 10 3D Bioprinters" in 2015. Ourobotics based in 🇮🇪 & 🇬🇧 founders: CEO-J. Redmond, me & CTO- Dr. A. Comerford. In 2016 Ourobotics were the 1st to open-source a basic extrusion 3D bioprinter "Renegade" for €900 from Imperial College London.